Control of intestinal stem cell fate: A novel approach to treating diabetes

Targeting L‐cell development and enrichment of incretin‐secreting cells could potentially evolve as novel, effective therapeutics for diabetes.[Image: see text]

Detalles Bibliográficos
Autores principales: Yamane, Shunsuke, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773665/
https://www.ncbi.nlm.nih.gov/pubmed/27042266
http://dx.doi.org/10.1111/jdi.12390
_version_ 1782418782770167808
author Yamane, Shunsuke
Inagaki, Nobuya
author_facet Yamane, Shunsuke
Inagaki, Nobuya
author_sort Yamane, Shunsuke
collection PubMed
description Targeting L‐cell development and enrichment of incretin‐secreting cells could potentially evolve as novel, effective therapeutics for diabetes.[Image: see text]
format Online
Article
Text
id pubmed-4773665
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47736652016-04-01 Control of intestinal stem cell fate: A novel approach to treating diabetes Yamane, Shunsuke Inagaki, Nobuya J Diabetes Investig Commentaries Targeting L‐cell development and enrichment of incretin‐secreting cells could potentially evolve as novel, effective therapeutics for diabetes.[Image: see text] John Wiley and Sons Inc. 2015-08-09 2016-03 /pmc/articles/PMC4773665/ /pubmed/27042266 http://dx.doi.org/10.1111/jdi.12390 Text en © 2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Commentaries
Yamane, Shunsuke
Inagaki, Nobuya
Control of intestinal stem cell fate: A novel approach to treating diabetes
title Control of intestinal stem cell fate: A novel approach to treating diabetes
title_full Control of intestinal stem cell fate: A novel approach to treating diabetes
title_fullStr Control of intestinal stem cell fate: A novel approach to treating diabetes
title_full_unstemmed Control of intestinal stem cell fate: A novel approach to treating diabetes
title_short Control of intestinal stem cell fate: A novel approach to treating diabetes
title_sort control of intestinal stem cell fate: a novel approach to treating diabetes
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773665/
https://www.ncbi.nlm.nih.gov/pubmed/27042266
http://dx.doi.org/10.1111/jdi.12390
work_keys_str_mv AT yamaneshunsuke controlofintestinalstemcellfateanovelapproachtotreatingdiabetes
AT inagakinobuya controlofintestinalstemcellfateanovelapproachtotreatingdiabetes

Ejemplares similares